Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer
Abstract
This Cochrane review of seven randomised controlled trials (1569 participants) found low-certainty evidence of a small improvement in five-year survival with adjunctive Coriolus (Trametes) versicolor extract (PSK) during colorectal cancer treatment, with uncertain effects on chemotherapy adverse effects.
Referenced for these plants
How to cite
Pilkington, K., Wieland, L.S., Teng, L., Jin, X.Y. and others (2022) 'Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer', Cochrane Database of Systematic Reviews, 11(11), pp. CD012053. doi:10.1002/14651858.CD012053.pub2
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.